Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia
AIM: The present study investigates the potential of Tadalafil, a phosphodiesterase-5 inhibitor, in a rat model of hyperhomocysteinemia induced vascular dementia.
METHODS: Hyperhomocysteinemia induced vascular dementia in Wistar rats was produced by administering l-Methionine (1.7 g/kg/day; p.o.×8 weeks). Learning and memory was assessed by employing Morris water maze (MWM) test. Endothelial dysfunction was assessed through acetylcholine-induced endothelial-dependent vasorelaxation and serum nitrite levels. Various other biochemical and histopathological estimations were also performed.
RESULTS: l-Methionine produced significant impairment in acetylcholine-induced endothelium-dependent vasorelaxation and a decrease in serum nitrite levels indicating endothelial dysfunction. Further, these animals performed poorly on Morris water maze, depicting impairment of learning and memory. There was a significant rise in brain oxidative stress level (indicated by an increase in brain thiobarbituric acid reactive species and a decrease in reduced glutathione levels). Increase in brain acetylcholinesterase activity; brain myeloperoxidase activity and brain neutrophil infiltration (a marker of inflammation) were also observed. Tadalafil (5 and 10 mg/kg, p.o.)/Donepezil (0.5 mg/kg, i.p., serving as standard) treatment ameliorated l-Methionine induced endothelial dysfunction; memory deficits; biochemical and histopathological changes in a significant manner.
CONCLUSIONS: It may be concluded that tadalafil has shown efficacy in the rat model of l-Methionine induced vascular dementia and that phosphodiesterase-5 can be considered as an important therapeutic target for the treatment of vascular dementia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:132 |
---|---|
Enthalten in: |
The International journal of neuroscience - 132(2022), 4 vom: 28. Apr., Seite 384-396 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bhatia, Pankaj [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 30.05.2022 Date Revised 01.06.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/00207454.2020.1817009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314323066 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314323066 | ||
003 | DE-627 | ||
005 | 20231225152459.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/00207454.2020.1817009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1047.xml |
035 | |a (DE-627)NLM314323066 | ||
035 | |a (NLM)32859137 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bhatia, Pankaj |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.05.2022 | ||
500 | |a Date Revised 01.06.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a AIM: The present study investigates the potential of Tadalafil, a phosphodiesterase-5 inhibitor, in a rat model of hyperhomocysteinemia induced vascular dementia | ||
520 | |a METHODS: Hyperhomocysteinemia induced vascular dementia in Wistar rats was produced by administering l-Methionine (1.7 g/kg/day; p.o.×8 weeks). Learning and memory was assessed by employing Morris water maze (MWM) test. Endothelial dysfunction was assessed through acetylcholine-induced endothelial-dependent vasorelaxation and serum nitrite levels. Various other biochemical and histopathological estimations were also performed | ||
520 | |a RESULTS: l-Methionine produced significant impairment in acetylcholine-induced endothelium-dependent vasorelaxation and a decrease in serum nitrite levels indicating endothelial dysfunction. Further, these animals performed poorly on Morris water maze, depicting impairment of learning and memory. There was a significant rise in brain oxidative stress level (indicated by an increase in brain thiobarbituric acid reactive species and a decrease in reduced glutathione levels). Increase in brain acetylcholinesterase activity; brain myeloperoxidase activity and brain neutrophil infiltration (a marker of inflammation) were also observed. Tadalafil (5 and 10 mg/kg, p.o.)/Donepezil (0.5 mg/kg, i.p., serving as standard) treatment ameliorated l-Methionine induced endothelial dysfunction; memory deficits; biochemical and histopathological changes in a significant manner | ||
520 | |a CONCLUSIONS: It may be concluded that tadalafil has shown efficacy in the rat model of l-Methionine induced vascular dementia and that phosphodiesterase-5 can be considered as an important therapeutic target for the treatment of vascular dementia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Phosphodiesterase-5 | |
650 | 4 | |a Tadalafil | |
650 | 4 | |a hyperhomocysteinemia | |
650 | 4 | |a memory | |
650 | 4 | |a oxidative stress | |
650 | 4 | |a vascular dementia | |
650 | 7 | |a Nitrites |2 NLM | |
650 | 7 | |a Phosphodiesterase 5 Inhibitors |2 NLM | |
650 | 7 | |a Tadalafil |2 NLM | |
650 | 7 | |a 742SXX0ICT |2 NLM | |
650 | 7 | |a Methionine |2 NLM | |
650 | 7 | |a AE28F7PNPL |2 NLM | |
650 | 7 | |a Acetylcholinesterase |2 NLM | |
650 | 7 | |a EC 3.1.1.7 |2 NLM | |
650 | 7 | |a Cyclic Nucleotide Phosphodiesterases, Type 5 |2 NLM | |
650 | 7 | |a EC 3.1.4.35 |2 NLM | |
650 | 7 | |a Acetylcholine |2 NLM | |
650 | 7 | |a N9YNS0M02X |2 NLM | |
700 | 1 | |a Singh, Nirmal |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The International journal of neuroscience |d 1970 |g 132(2022), 4 vom: 28. Apr., Seite 384-396 |w (DE-627)NLM000202495 |x 1563-5279 |7 nnns |
773 | 1 | 8 | |g volume:132 |g year:2022 |g number:4 |g day:28 |g month:04 |g pages:384-396 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/00207454.2020.1817009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 132 |j 2022 |e 4 |b 28 |c 04 |h 384-396 |